Impact of innovative activity of organizations on the development of pharmaceutical industry: a case study

Natalia Leonidovna Borscheva (), Yulia Vyacheslavovna Fedorova (), Marina Ivanovna Glukhova () and Guzal Ilgizovna Islamova ()
Additional contact information
Natalia Leonidovna Borscheva: I.M. Sechenov First Moscow State Medical University, Russian Federation
Yulia Vyacheslavovna Fedorova: I.M. Sechenov First Moscow State Medical University, Russian Federation
Marina Ivanovna Glukhova: I.M. Sechenov First Moscow State Medical University, Russian Federation
Guzal Ilgizovna Islamova: I.M. Sechenov First Moscow State Medical University, Russian Federation

Entrepreneurship and Sustainability Issues, 2020, vol. 7, issue 4, 3001-3015

Abstract: Тhe article proposes a new methodological approach to the study and evaluation of external factors affecting innovation activity. External factors were estimated, a correlation model was built, and key factors affecting innovation activity and susceptibility to innovation of Russian companies were identified. A regression model reflecting the dependence of the level of innovation activity of Russian companies on changes in environmental factors in the dynamics from 2006 to 2016 was constructed. The study was conducted on the basis of statistical data on the development of the pharmaceutical industry as one of the high-tech industries of the Russian industry. The study confirmed and measured the relationship between the macro factors of development of the Russian pharmaceutical industry and the volume of its production. This study is an occasion to discuss and further study the development of sound recommendations to change or improve the state industrial policy. Directions of further researches are connected with a deeper study of the causes of interrelation of volume of output and macroeconomic factors, as well as with the assessment of the temporal distribution of the macroeconomic consequences of purposeful influence on the magnitude of the factors considered.

Keywords: management; innovative activity; innovative development; model; external environment factors; pharmaceutical industry (search for similar items in EconPapers)
JEL-codes: O11 O31 O32 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://jssidoi.org/jesi/uploads/articles/28/Borsc ... try_a_case_study.pdf (application/pdf)
https://jssidoi.org/jesi/article/568 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ssi:jouesi:v:7:y:2020:i:4:p:3001-3015

DOI: 10.9770/jesi.2020.7.4(29)

Access Statistics for this article

Entrepreneurship and Sustainability Issues is currently edited by Manuela Tvaronaviciene

More articles in Entrepreneurship and Sustainability Issues from VsI Entrepreneurship and Sustainability Center
Bibliographic data for series maintained by Manuela Tvaronaviciene ().